DelveInsight Reports Sitemap

All Reports in this category
S.No. Product Name Actions
1 Acne Vulgaris Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
2 Acromegaly - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
3 Actinic Keratosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
4 Acute Coronary Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
5 Allergic Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
6 Allergic Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
7 Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
8 Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
9 Angina - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
10 Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
11 Aspergillosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
12 Autism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
13 Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
14 Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
15 Bacterial Pneumonia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
16 B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
17 B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
18 Behcet's Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
19 Biliary Tumor - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
20 Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
21 Chemotherapy Induced Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
22 Chronic Kidney Disease (Chronic Renal Failure) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
23 Chronic Liver Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
24 Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
25 Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
26 Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
27 Hyperuricemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
28 Oral Mucositis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
29 Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
30 Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
31 Open-Angle Glaucoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
32 Nosocomial Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
33 Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
34 Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
35 Myelofibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
36 Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
37 Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
38 Nocturia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
39 Myasthenia Gravis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
40 Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
41 Metastatic Hepatocellular Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
42 Medullary Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
43 Malignant Mesothelioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
44 Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
45 Metastatic Renal Cell Carcinoma (mRCC) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
46 Anterior Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
47 Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
48 Blepharitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
49 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
50 Dyspepsia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
51 Endometriosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
52 Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
53 Venous Thromboembolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
54 Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
55 Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
56 Esophageal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
57 Febrile Neutropenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
58 Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
59 Familial Amyloid Polyneuropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
60 Gastrointestinal Stromal Tumor (GIST) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
61 Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
62 Hairy Cell Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
63 Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
64 Hematopoietic Stem Cell Transplantation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
65 Hemophilia B - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
66 Hemostasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
67 Hepatitis D - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
68 Hypertriglyceridemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
69 Hot Flashes - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
70 Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
71 Idiopathic Pulmonary Fibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
72 Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
73 Hypersomnia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
74 Hyperphosphatemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
75 Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
76 Gastritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
77 Gastroparesis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
78 Idiopathic Short Stature - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
79 Infantile Spasm - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
80 Ischemic Stroke - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
81 Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
82 Left Ventricular Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
83 Liposarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
84 Liver Failure - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
85 Moderate Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
86 Lupus Nephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
87 Paroxysmal Nocturnal Hemoglobinuria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
88 Partial Seizure - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
89 Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
90 Impetigo - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
91 Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
92 Influenza A Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
93 Waldenstrom Macroglobulinemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
94 Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
95 Otitis Media - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
96 Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
97 Peptic Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
98 Insulin Resistance - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
99 Iron Deficiency Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
100 Short Bowel Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
101 Varicella Zoster (HHV-3) Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
102 Vancomycin-Resistant Enterococcus Faecium Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
103 Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
104 Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
105 Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
106 Peripheral Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
107 Pruritus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
108 Tourette Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
109 Urinary Incontinence - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
110 Uterine Leiomyoma (Uterine Fibroids) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
111 Sarcoidosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
112 Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
113 Sinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
114 Sleep Apnea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
115 Smallpox - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
116 Soft Tissue Sarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
117 Spasticity - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
118 Spinal Muscular Atrophy (SMA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
119 Systemic Lupus Erythematosus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
120 Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
121 Systemic Mastocytosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
122 Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
123 Phenylketonuria (PKU) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
124 Rhinosinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
125 Rosacea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
126 Seasonal Allergic Rhinitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
127 Secondary Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
128 Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
129 Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
130 Seizures - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
131 Severe Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
132 Thrombocytopenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
133 Thrombotic Thrombocytopenic Purpura - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
134 Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
135 Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
136 Polycythemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
137 Traveler's Diarrhea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
138 Pompe Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
139 Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
140 Post Menopausal Osteoporosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
141 Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
142 Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
143 Pouchitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
144 Premature Ejaculation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
145 Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
146 Primary Biliary Cirrhosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
147 Primary Immune Deficiency (PID) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
148 Psoriatic Arthritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
149 Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
150 Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
151 Pyelonephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
152 Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
153 Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
154 Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
155 Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
156 Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
157 Renal Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
158 Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
159 Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link
160 Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Report Link